Acute bacterial rhinosinusitis
First line
Drug of choice in adults and children when bacterial etiology is suspected per 2012 and . Adults: amoxicillin 500 mg TID or 875 mg BID for 5–7 days. In regions with high S. pneumoniae resistance or with risk factors, amoxicillin/clavulanate is used. Indications for antibiotics: symptoms over 10 days, worsening after initial improvement, severe onset with fever ≥ 39 °C and purulent discharge.
Sources
- NICE NG79 'Sinusitis (acute): antimicrobial prescribing': NICE NG79 'Sinusitis (acute): antimicrobial prescribing' (0)
- Clin Infect Dis: IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. (2012)
- Otolaryngology–Head and Neck Surgery: Clinical Practice Guideline (Update) (2015)
- Cochrane Database of Systematic Reviews: Antibiotics for acute maxillary sinusitis in adults (2014)